Brief: ADMA Biologics Highlights Expanded Intellectual Property Portfolio For Specialty Plasma Derived Immune Globulins Targeted Against Respiratory Infections
03/03/2020 12:15
March 3 (Reuters) - ADMA Biologics Inc ADMA.O :
* ADMA BIOLOGICS HIGHLIGHTS EXPANDED INTELLECTUAL PROPERTY
PORTFOLIO FOR SPECIALTY PLASMA DERIVED IMMUNE GLOBULINS TARGETED
AGAINST RESPIRATORY INFECTIONS
Source text for Eikon: ID:nGNX5x6Lby
Further company coverage: ADMA.O
((Reuters.Briefs@thomsonreuters.com;))